Important Information For Your Reference

1. Common side effects include: drowsiness, blurred vision, dry mouth. For a full list of information
   Side Effects:
   
   see hereSee Less
2. Do not take this if you are allergic to the medicine or its composition. If you're unsure, check with us or your doctor.
3. Severe allergic reactions such as severe rash, severe itchiness and fever, swollen throat, face, eyelids or lips can happen. Stop taking this medication and speak to your doctor immediately if you experience these symptoms. This reaction may start soon after you first take the medicine, or it might start later.
4. Other important information for pregnant women/children/elderly users, please
   
   Alcohol Warning (No Data)
   

   Windexco PE Syrup 120ml and alcohol consumption may worsen the effects on the central nervous system as their adverse reactions may be compounded. It is safe to consume alcohol with Windexco PE Syrup 120ml as there is no known drug interaction. There is no contraindication in alcohol consumption while using Windexco PE Syrup 120ml.

   
   Pregnancy Warning (No Data)
   

   There are mixed and inadequate data to conclude the safety profile of Chlorpheniramine in pregnant women. It may be safe to use in the first and second trimester but may increase the risk of premature neonates if used in the third trimester. Special precautions must be taken into consideration to use Windexco PE Syrup 120ml during pregnancy. There is no animal reproductive studies conducted but due to potential adverse effects of Windexco PE Syrup 120ml to the term fetus, it is not advisable to take Windexco PE Syrup 120ml during pregnancy.

   
   Breastfeeding Warning (No Data)
   

   Windexco PE Syrup 120ml is present in small quantity in human breastmilk and can cause drowsiness on the infant. Close monitoring is required if using Windexco PE Syrup 120ml during breastfeeding or using second generation of anti-histamine. Windexco PE Syrup 120ml should be used with caution during lactation as there is no information regarding the presence of Windexco PE Syrup 120ml in human breast milk. It is not known whether Windexco PE Syrup 120ml is excreted into human breastmilk or not. Due to its potential toxicity, Windexco PE Syrup 120ml is not advisable to be used during breastfeeding.

   
   Driving Warning (No Data)
   

   It is not advisable to drive when taking Windexco PE Syrup 120ml due to its potential side effects such as drowsiness and dizziness which can affect the ability to drive and concentrate. Windexco PE Syrup 120ml may cause side effects such as dizziness, headache, all of which could affect your ability to concentrate and drive. It is not advisable to drive when under Windexco PE Syrup 120ml eye treatment due to its potential side effects such as eye irritation and blurred vision which can affect the ability to concentrate and drive.

   
   Kidney Warning (No Data)
   

   No dosage adjustment is needed for people with renal impairment despite it being excreted via urine. Dose adjustment of Windexco PE Syrup 120ml is not needed in patients with kidney disease. Dosage adjustment may be needed for patient who needs parenteral Windexco PE Syrup 120ml and with hypotensive states.

   
   Liver Warning (No Data)
   

   Although no dosage adjustment is indicated by the manufacturer labelling, precautionary measure with dosage adjustment may be needed in moderate to severe hepatic impaired patient due to Windexco PE Syrup 120ml being metabolised by the liver. No dose titration of Windexco PE Syrup 120ml is required in patients with liver disease. There is no dosage adjustment needed for patients with hepatic impairment according to the manufacturer labelling.

   
   
   refer hereSee Less
5. Recommended dosage: Adult: Take 10ml up to THREE times daily. Children above 6 years: Give 5ml up to THREE times daily as required. Consult your doctor if child is below 6 years.